In many organisms, prolonged exposure to nicotine causes long-lasting changes in the abundance and functional activity of nicotinic receptors, processes thought to underlie nicotine addiction in humans. At present, the molecular basis for nicotine adaptation is poorly understood. We have begun using a genetic approach to identify molecules required for nicotine adaptation in the egg-laying circuitry of C. elegans. Acute exposure to nicotine or the nicotinic agonist levamisole have dramatic effects on behavior, including stimulation of egg-laying. These acute effects of nicotine on egg-laying require the activity of a nicotinic receptor containing subunits
unc-29,
unc-38, and
lev-1, as mutations in these genes confer resistance to nicotine and levamisole. This receptor appears to function in the vulval muscle, since expression of an
unc-29 transgene under a vulval muscle-specific promoter in
unc-29 mutant animals restored egg-laying sensitivity to levamisole. Upon long-term nicotine treatment, wildtype worms undergo adaptation, and acquire a long-lasting loss of egg-laying sensitivity. This effect is at least partially mediated at the level of receptor abundance, as the expression of an UNC-29:GFP chimera was drastically reduced upon overnight treatment with nicotine. In order to identify molecules required for the long-term effects of nicotine, we examined known mutants and screened for new mutants with defects in adaptation. From the known mutants,
tpa-1, a PKC homologue, was shown to be necessary for the control of UNC-29 receptor abundance, since
tpa-1 mutants remained sensitive to levamisole and retained high UNC-29 receptor levels in the vulval muscles even after long-term nicotine treatment. We also identified a new gene,
nic-1, in a screen for adaptation defective mutants. These mutants displayed hypersensitivity to nicotine and a defect in adaptation, as well as an unusual locomotive phenotype and a deficiency in male mating ability, all of which are consistent with a defect in cholinergic function in the neuromusculature. Currently, we are in the process of mapping
nic-1 in order to clone it, and hope to discover the identity of the molecule encoded by this gene.